FR2453152A1 - NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM - Google Patents

NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM

Info

Publication number
FR2453152A1
FR2453152A1 FR8007320A FR8007320A FR2453152A1 FR 2453152 A1 FR2453152 A1 FR 2453152A1 FR 8007320 A FR8007320 A FR 8007320A FR 8007320 A FR8007320 A FR 8007320A FR 2453152 A1 FR2453152 A1 FR 2453152A1
Authority
FR
France
Prior art keywords
prostaglandin derivatives
medicaments containing
new prostaglandin
hydroxy
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8007320A
Other languages
French (fr)
Other versions
FR2453152B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/026,066 external-priority patent/US4243611A/en
Priority claimed from US06/025,899 external-priority patent/US4228104A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2453152A1 publication Critical patent/FR2453152A1/en
Application granted granted Critical
Publication of FR2453152B1 publication Critical patent/FR2453152B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids

Abstract

L'invention a trait au domaine de la chimie pharmaceutique. Elle concerne de nouveaux dérivés de prostaglandine de forme 19,20-didéhydro, 19-hydroxy ou 19-céto, dont un exemple 19-hydroxylé représentatif est l'ester méthylique de 19-hydroxy-èî-méthyl-PGF 2 alpha de formule :The invention relates to the field of pharmaceutical chemistry. It relates to new prostaglandin derivatives of 19,20-didehydro, 19-hydroxy or 19-keto form, a representative 19-hydroxylated example of which is 19-hydroxy-èî-methyl-PGF 2 alpha methyl ester of formula:

FR8007320A 1979-04-02 1980-04-01 NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM Granted FR2453152A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2587979A 1979-04-02 1979-04-02
US2587879A 1979-04-02 1979-04-02
US06/026,066 US4243611A (en) 1979-04-02 1979-04-02 2-Decarboxy-2-hydroxymethyl-19,20-didehydro PG2 compounds
US06/025,899 US4228104A (en) 1979-04-02 1979-04-02 2-Decarboxy-2-hydroxymethyl-19-hydroxy-PG1 analogs

Publications (2)

Publication Number Publication Date
FR2453152A1 true FR2453152A1 (en) 1980-10-31
FR2453152B1 FR2453152B1 (en) 1985-04-12

Family

ID=27487451

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8007320A Granted FR2453152A1 (en) 1979-04-02 1980-04-01 NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM

Country Status (4)

Country Link
DE (1) DE3012249A1 (en)
FR (1) FR2453152A1 (en)
GB (1) GB2048254B (en)
IT (1) IT1141908B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010473A2 (en) * 1990-12-06 1992-06-25 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
EP0533828A1 (en) * 1990-06-14 1993-03-31 Allergan Inc Pgf 1-alcohols and their use as ocular hypotensives.

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766163B2 (en) 1999-03-05 2003-10-09 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2285124A1 (en) * 1974-09-19 1976-04-16 Sankyo Co PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
US4036876A (en) * 1973-07-13 1977-07-19 Syntex (U.S.A.) Inc. 18- AND 19-Hydroxylated prostaglandins
US4127612A (en) * 1978-03-17 1978-11-28 Miles Laboratories, Inc. 19-Hydroxy PGE1 carbinol analogues
FR2460944A1 (en) * 1979-07-05 1981-01-30 Upjohn Co PROSTACYCLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036876A (en) * 1973-07-13 1977-07-19 Syntex (U.S.A.) Inc. 18- AND 19-Hydroxylated prostaglandins
FR2285124A1 (en) * 1974-09-19 1976-04-16 Sankyo Co PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
US4127612A (en) * 1978-03-17 1978-11-28 Miles Laboratories, Inc. 19-Hydroxy PGE1 carbinol analogues
FR2460944A1 (en) * 1979-07-05 1981-01-30 Upjohn Co PROSTACYCLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THE SAME

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533828A1 (en) * 1990-06-14 1993-03-31 Allergan Inc Pgf 1-alcohols and their use as ocular hypotensives.
EP0533828A4 (en) * 1990-06-14 1993-08-11 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives
WO1992010473A2 (en) * 1990-12-06 1992-06-25 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
WO1992010473A3 (en) * 1990-12-06 1992-08-20 Allergan Inc 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives

Also Published As

Publication number Publication date
GB2048254A (en) 1980-12-10
FR2453152B1 (en) 1985-04-12
IT8021050A0 (en) 1980-03-28
IT1141908B (en) 1986-10-08
GB2048254B (en) 1983-05-25
DE3012249A1 (en) 1980-10-16

Similar Documents

Publication Publication Date Title
FR2416234A1 (en) METRONIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING
FR2416012A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
FR2442851A1 (en) NEW SPIRO (4 H-2,3-DIHYDROVENZOPYRANNE (4,5 ') OXAZOLIDINE) -2', 4'-DIONES AND MEDICINAL CONTAINER
FR2398748A1 (en) NEW DERIVATIVES OF IMIDAZOQUINAZOLINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2430410A1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2444031A1 (en) NOVEL IMIDAZOLE DERIVATIVES, THEIR PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2432519A1 (en) NOVEL PURINE DERIVATIVES AND MEDICAMENTS CONTAINING THEM
FR2424913A1 (en) NEWS 4- (QUINOLINYLAMINOBENZOYL) PIPERAZINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2374307A1 (en) 1,4-DIHYDROPYRIDINE DERIVATIVES, THE PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2376134A1 (en) 6-OXO-PROSTAGLANDIN DERIVATIVES, THEIR PREPARATION PROCESS AND MEDICINAL PRODUCTS CONTAINING
FR2453152A1 (en) NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM
FR2358382A1 (en) NEW NONAPEPTIDES, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2393577A1 (en) B- (P-HALOGENOPHENYL) -G-AMINOBUTYRIC ACID BASED MEDICINAL PRODUCT FOR THE TREATMENT OF ANXIETY NEPROSIS
FR2446819A1 (en) 6-ALKYL DERIVATIVES OF 1,2-DIHYDRO-2-OXONICOTINIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2415103A1 (en) ACIDS AND DERIVATIVES OF 4-PYRIDONE-3-CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2429019A1 (en) DRUGS CONTAINING 1-B-D-ARABINOFURANOSYLCYTOSINE-5'-PHOSPHATE ESTERS
FR2426039A1 (en) DERIVATIVES OF DI-O-N-ALKYLGLYCEROLS AND IMMUNO-STIMULATING MEDICINAL PRODUCTS CONTAINING THEM
FR2368959A1 (en) COMPOSITIONS CONTAINING GUANIDINOALCANOIC ACID DERIVATIVES, USED AS A MEDICINAL PRODUCT
FR2401141A1 (en) NEW HALOGEN DERIVATIVES OF PROSTAGLANDINS AND MEDICINES CONTAINING THEM
FR2355012A1 (en) NEW DERIVATIVES OF DIHYDRO- AND TETRAHYDRO-IMINOTHIAZINE, AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2361361A1 (en) NEW DERIVATIVES OF CYCLOPENTANE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
FR2401160A1 (en) NEW VINCAMINOL ESTERS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2375211A1 (en) NEW SULFAMOYLBENZOIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2379538A1 (en) NEW OXADIAZOLOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2430947A1 (en) NOVEL 2-AMINO-OCTAHYDRO-INDOLO- (2,3-A) -QUINAZOLINE COMPOUNDS, PROCESS FOR PRODUCING THEM AND MEDICINAL PRODUCTS CONTAINING THEM

Legal Events

Date Code Title Description
ST Notification of lapse